Search our science

Search our scientific publications and resources
on rare bleeding disorders

Molecule
Study Phase
Content Type


Scientific resources from Novo Nordisk

Novo Nordisk supports sharing of the scientific research on our molecules. The search results below include peer-reviewed articles that are authored by Novo Nordisk employees or are funded by Novo Nordisk, as well as congress abstracts, posters and presentations, and also related educational resources.

 

Search Results

We found 298 resources matching your search criteria

Animated publication summary

Wu R, Sun J, Xu W, Hu Q, Li W, Xiao J, Yang F, Zeng X, Zeng Y, Zhou J, Matytsina I, Zhang S, Pluta M, Yang R. Safety and Efficacy of Turoctocog Alfa in the Prevention and Treatment of Bleeding Episodes in Previously Treated Patients from China with Severe Hemophilia A: Results from the Guardian 7 Trial. Ther Clin Risk Manag. 2020;16:567-578

Primary manuscript
Wu R, Sun J, Xu W, Hu Q, Li W, Xiao J, Yang F, Zeng X, Zeng Y, Zhou J, Matytsina I, Zhang S, Pluta M, Yang R. Safety and Efficacy of Turoctocog Alfa in the Prevention and Treatment of Bleeding Episodes in Previously Treated Patients from China with Severe Hemophilia A: Results from the Guardian 7 Trial. Ther Clin Risk Manag. 2020;16:567-578
Primary manuscript
Wang M, Peltier S, Baumann K, Sidonio R, Witkop M, Cooper D, Waters E, Kahan S, Croteau S, Cutter S, Hernandez G, Wicklund B, Dreyer Gillette M, Haugstad K, Ostrow V, Nadglowski J. ACTION-TO-HOPE HCP and Consumer Results Supplement. Haemophilia. 2020;26(S1):3-19.
Poster
Walsh KS, Mraskotsky C, Shapiro KA, Wilkening GN, Croteau SE, Rajpurkar M, Buranahirun C, Hannemann C, Maruff P, Ventola P, Cooper DL. A Methodologic Approach to Assessment of Cognitive Function in Congenital Hemophilia Using Hemophilia Normative Data (eTHINK) to Assess Children Exposed to GlycoPEGylated Factor IX (N9-GP) in the paradigm 5/6 Trials. International Neuropsychological Society - 48th Annual Meeting. 2020;
Abstract
Walsh KS, Mraskotsky C, Shapiro KA, Wilkening GN, Croteau SE, Rajpurkar M, Buranahirun C, Hannemann C, Maruff P, Ventola P, Cooper DL. A Methodologic Approach to Assessment of Cognitive Function in Congenital Hemophilia Using Hemophilia Normative Data (eTHINK) to Assess Children Exposed to GlycoPEGylated Factor IX (N9-GP) in the paradigm 5/6 Trials. International Neuropsychological Society - 48th Annual Meeting. 2020;
Abstract
Kjellev S, Østergaard H, Greisen PJ, Hermit MB, Thorn K, Hansen BG, Zhou R, Zhiru Y, Bjelke JR, Kjalke M, Lund J, Holm TL, Ley CD, Madsen DE, Thygesen P, Loftager M, Gandhi P, Lamberth K, Rasch MG, Egebjerg T, Lund S, Lorenzen N, Henriksen A, Rahbek-Nielsen H, Hilden I. Preclinical characterisation of Mim8 – A next-generation FVIII mimetic bispecific antibody. Haemophilia. 2020;26(S2):43-44. P035.
Poster
Kjellev S, Østergaard H, Greisen PJ, Hermit MB, Thorn K, Hansen BG, Zhou R, Zhiru Y, Bjelke JR, Kjalke M, Lund J, Holm TL, Ley CD, Madsen DE, Thygesen P, Loftager M, Gandhi P, Lamberth K, Rasch MG, Egebjerg T, Lund S, Lorenzen N, Henriksen A, Rahbek-Nielsen H, Hilden I. Preclinical characterisation of Mim8 – A next-generation FVIII mimetic bispecific antibody. European Association for Haemophilia and Allied Disorders - 13th Annual Congress. 2020.
Poster
Ley CDD, Kjalke M, Holm TL, Madsen DE, Holmberg HL, Lauritzen B, Larsen LF, Bjelke JR, Stavenuiter F, Loftager M, Hermit MB, Hilden I, Kjellev SR. Improved effect of Mim8, a next-generation FVIII mimetic, translates from human in vitro to humanized mouse and cynomolgus models. European Association for Haemophilia and Allied Disorders - 13th Annual Congress. 2020.
Primary manuscript
Hassan Yaish, Tadashi Matsushita, Meriem Fadila Belhani, Víctor Jiménez Yuste, Kaan Kavakli, Lars Korsholm, Irina Matytsina, Claire Philipp, Kirsten Reichwald, Runhui Wu. Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeds in previously untreated paediatric patients with severe haemophilia A: results from the guardian 4 multinational clinical trial. Haemophilia. 2020;26(1):64-72.

This website is intended
for healthcare professionals (HCPs)
outside of the U.S.

Take me to www.novonordisk.com